Jennifer Reynolds
Stories (16)
Filter by community
Top Biosimilars Companies in 2025. AI-Generated.
The global biosimilars market is expected to grow from USD 35.04 billion in 2025 to USD 72.29 billion by 2035, registering a compound annual growth rate (CAGR) of 7.5% during the forecast period. This growth is driven by rising adoption rates, supportive regulatory frameworks, and a growing acceptance among healthcare professionals to include biosimilars in treatment regimens.
By Jennifer Reynolds3 months ago in Journal
Top Digital Health Companies in 2025 . AI-Generated.
Prominent players in the market include Medtronic (Ireland), Abbott (US), OMRON Healthcare, Inc. (Japan), Koninklijke Philips N.V. (Netherlands), Apple Inc. (US), Fitbit (US), Dexcom, Inc. (US), Boston Scientific Corporation (US), Masimo (US), Teladoc Health, Inc. (US), American Well (US), Hims & Hers Health, Inc. (US), Headspace inc. (US), Noom, Inc. (US), Cerebral Inc. (US), Epic System Corporation (US), Omada Health Inc. (US), Oracle (US), Click Therapeutics, Inc. (US), Welldoc, Inc. (US), and EverlyWell (US).
By Jennifer Reynolds3 months ago in Journal
Synthetic Biology Market worth $31.52 billion by 2029. AI-Generated.
The report "Synthetic Biology Market by Tools (Oligonucleotides, Enzymes, Synthetic Cells), Technology (Sequencing, Bioinformatics), Applications (Drug Discovery, Tissue Regeneration, Biofuel, Food, Agriculture, Consumer Care, Environmental) - Global Forecast to 2029", is estimated to expand to a value of USD 31.52 billion by 2029 from USD 12.33 billion in 2024, with a significant CAGR of 20.6%. Some of the prominent factors driving the growth of the market are the rising demand for bio-based products and rising funding in R&D and collaborations. Furthermore, Advancements in synthetic biology and the diverse applications of synthetic biology are expected to provide lucrative market growth. The demand for synthetic DNA and oligonucleotides is growing, driven by diversified applications in research, diagnostics, and therapeutic development. This factor is likely to contribute to the growth of synthetic biology, particularly in the healthcare and biotechnology field.
By Jennifer Reynolds3 months ago in Journal
Top CRISPR Companies in 2025. AI-Generated.
The global CRISPR market is projected to increase from USD 3.21 billion in 2025 to USD 5.47 billion by 2030, registering a robust CAGR of 11.2% during the forecast period. The market is highly competitive, with several major players striving to expand their market presence. Prominent companies operating in the CRISPR market include Thermo Fisher Scientific Inc. (US), Agilent Technologies Inc. (US), Merck KGaA (Germany), and GenScript (US), among others. These leading players are pursuing a range of growth strategies—both organic and inorganic—such as partnerships, agreements, expansions, and acquisitions, to strengthen their market position and drive innovation in CRISPR technologies.
By Jennifer Reynolds3 months ago in Journal
Top defibrillator Companies in 2025. AI-Generated.
The global defibrillator market is projected to grow from USD 11.99 billion in 2025 to USD 16.44 billion by 2030, registering a CAGR of 6.5% during the forecast period. Market growth is driven by the rising incidence of cardiac arrest among patients with cardiovascular diseases, increasing government and private initiatives to install defibrillators in public spaces for improved emergency response, and expanding training and awareness programs related to defibrillator use. Additionally, advancements in subcutaneous implantable cardioverter-defibrillators (S-ICDs), MRI-compatible ICDs and CRT-Ds, along with the ongoing enhancement of healthcare infrastructure in emerging economies, are expected to further fuel market expansion.
By Jennifer Reynolds3 months ago in Journal
United States Single-Use Bioreactors Market Poised for Transformative Growth Driven by Innovation and Industry Adoption . AI-Generated.
The American single-use bioreactors industry continues to demonstrate remarkable momentum as biopharmaceutical manufacturers increasingly pivot toward flexible, cost-effective production solutions. The country maintains its position as the global leader in this transformative market segment, driven by substantial research and development investments, innovative manufacturing practices, and a robust biopharmaceutical ecosystem.
By Jennifer Reynolds3 months ago in Journal
United States Pet Insurance Market Poised for Transformative Growth as Pet Humanization and Digital Innovation Reshape Industry Landscape . AI-Generated.
The pet insurance industry is experiencing a remarkable period of expansion, fueled by fundamental shifts in how Americans view and care for their companion animals. The global pet insurance market is projected to surge from USD 14.35 billion in 2025 to USD 29.80 billion by 2030, growing at a compound annual growth rate of 15.7% during the forecast period. This dynamic growth trajectory reflects the increasing financial awareness among pet owners about the escalating costs of veterinary care and the critical need for comprehensive insurance protection.
By Jennifer Reynolds3 months ago in Journal
Global Wound Care Market Set to Surpass USD 30.48 Billion by 2030 . AI-Generated.
The global wound care market, valued at US$20.97 billion in 2024, stood at US$22.22 billion in 2025 and is projected to advance at a resilient CAGR of 6.5% from 2025 to 2030, culminating in a forecasted valuation of US$30.48 billion by the end of the period. This growth is propelled by an upsurge in traumatic and burn injuries, the increasing prevalence of chronic diseases, and the swelling ranks of the geriatric population. Governments and healthcare providers are also driving adoption through supportive reimbursement frameworks, while new technologies are redefining care delivery.
By Jennifer Reynolds3 months ago in Journal
United States Biosimulation Market Poised for Transformative Growth Driven by AI Integration and Regulatory Adoption . AI-Generated.
The biosimulation industry continues its remarkable expansion trajectory, fundamentally transforming how pharmaceutical and biotechnology companies approach drug discovery and development. The market, which achieved a valuation of $3.64 billion in 2023 and expanded to $4.24 billion in 2024, is projected to reach $9.18 billion by 2029, advancing at a compound annual growth rate of 16.7% throughout the forecast period.
By Jennifer Reynolds3 months ago in Journal
United States Cannabis Testing Market Poised for Unprecedented Growth Amid Rising Legalization and Quality Assurance Demands . AI-Generated.
The global cannabis testing market has emerged as a critical component of the rapidly evolving cannabis industry, with comprehensive new research revealing transformative growth trajectories driven by widespread legalization efforts and heightened consumer safety standards. The market, which achieved a valuation of $1.6 billion in 2023 and reached $1.8 billion in 2024, is projected to experience remarkable expansion at a compound annual growth rate of 17.2% through 2029, culminating in an anticipated valuation of $4.0 billion by the end of the forecast period.
By Jennifer Reynolds3 months ago in Journal
Germany Remote Patient Monitoring Market Poised for Substantial Growth as Digital Health Revolution Reshapes Patient Care Delivery . AI-Generated.
The global remote patient monitoring (RPM) market is experiencing unprecedented expansion, advancing from a valuation of US$27.72 billion in 2024 to a projected US$56.94 billion by 2030, representing a robust compound annual growth rate (CAGR) of 12.7% throughout the forecast period. This remarkable growth trajectory reflects a fundamental transformation in healthcare delivery, driven by technological innovation, changing patient preferences, and the pressing need to manage chronic diseases more effectively.
By Jennifer Reynolds3 months ago in Journal
Germany Wound Care Market: Global Industry Poised to Reach US$30.48 Billion by 2030 Amid Rising Chronic Disease Prevalence and Technological Innovation. AI-Generated.
The global wound care market is experiencing robust growth, with valuations climbing from US$20.97 billion in 2024 to US$22.22 billion in 2025. Industry analysts project the market will advance at a compound annual growth rate (CAGR) of 6.5% through 2030, reaching an estimated US$30.48 billion by the end of the forecast period. This sustained expansion reflects the growing global need for sophisticated wound management solutions driven by demographic shifts, rising injury rates, and technological breakthroughs in treatment methodologies.
By Jennifer Reynolds3 months ago in Journal
